Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

House Republicans are pushing to repeal a provision in the shutdown-ending funding measure that would allow senators to earn ...

A Google Cloud partner, Master Builder model represents MatrixC's proprietary push to build own solutions STAX-GPT developed ...